Lidocaine/tetracaine patch
DrugOther names: Ralydan
NCT Number: NCT02519660
Needle-related procedures are among the most common sources of pain and distress for children in the health care setting. More than 50% of children reported pain during these procedures. The necessity for pain management during these procedures is well established. Topical anesthesia has been shown to be effective in managing needle-related pain. Eutectic mixture of local anaesthetic (EMLA) cream is the topical anesthetic most used. The application of this mixture of lidocaine and prilocaine reduce pain during needle procedures in children. To be effective EMLA cream must be applied for at least 60 minutes before needle procedure. This is the major limitation for its use in emergency settings.
Ralydan patch is a drug delivery system designed to release local anaesthetics (lidocaine and tetracaine) through the skin. There is evidence of pain relief after 30 minutes from its application. Only one randomized controlled trial compared the two topical anaesthetics in children during venipuncture and showed that Ralydan patch led to superior analgesia than EMLA cream, even if in this study the two anaesthetics were applied only for 35 minutes before needle procedure. No differences were found in success rate of the procedure and vein visibility. In adult patients, Ralydan and EMLA were equally effective in pain relief after 60 minutes from application.
To the best of the investigators' knowledge there is no published study that compared needle procedure success rate in children and pain relief effectiveness of lidocaine/tetracaine patch and lidocaine/prilocaine cream, at time of their maximum analgesic effect.
The aim of this study is to compare Ralydan patch and EMLA cream at time of their maximum analgesic effect (30 minutes vs 60 minutes), regard to needle procedure success rate at the first attempt and pain relief in children.
Looking for future studies?
Notify Me3 year–10 year
All sexes
Interventional
Phase 3
Ospedale Pediatrico Pausilipon - Servizio di terapia del dolore e cure palliative, Naples, Campania, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Ralydan
Other names: EMLA
Time frame: Intraoperative
Percentage of success at first attempt
Time frame: Intraoperative
The pain during the procedure will be evaluate using pain rating scale appropriate for age
Time frame: Up to 15 minutes after the procedure
The number and the type of adverse events will be recorded
IRCCS Burlo Garofolo
Other
Lidocaine/Tetracaine Patch (Ralydan) vs Lidocaine/Prilocaine Cream (EMLA) for Needle Related Procedures in Children: a Multicenter, Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06901271
Fear Pain, Neurologic Manifestations
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07707791
Anxiety, Anxiety Disorders
View Trial DetailsNCT07292337
Agnosia, Genital Diseases
Kuala Lumpur, Malaysia
View Trial DetailsNCT07178379
Agnosia, Gynecologic Procedure
View Trial Details